Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
Clinical trial NCT00217425 · COMPLETED
Trial details
- NCT number
- NCT00217425
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-14
- Primary completion
- 2012-04-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.